1,2,4-triaminobenzene derivatives useful for treating disorders of the central nervous system

Details for Australian Patent Application No. 2003287922 (hide)

International Classifications

Event Publications

1 April 2004 Complete Application Filed

Priority application(s): PA200202012 27.12.02 DK

26 August 2004 Application Open to Public Inspection

Published as AU-B-2003287922

18 August 2005 Amendment Made

The nature of the amendment is: Delete priority details 60/436,697 27 Dec 2002 US 2003290019 Novartis AG The nature of the amendment is: Add coinventors Erb, Bernard; Pachinger, Werner

10 December 2009 Application Accepted

Published as AU-B-2003287922

24 June 2010 Standard Patent Sealed

14 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.